Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days

BACKGROUND: Cholera, an acute watery diarrhoeal disease caused by Vibrio cholerae serogroup O1 and O139 across the continents. Replacing the existing WHO licensed killed multiple-dose oral cholera vaccines that demand ‘cold chain supply’ at 2–8 °C with a live, single-dose and cold chain-free vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Xian, Tew Hui, Sinniah, Kurunathan, Yean, Chan Yean, Krishnamoorthy, Venkateskumar, Bahari, Mohd Baidi, Ravichandran, Manickam, Prabhakaran, Guruswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249306/
https://www.ncbi.nlm.nih.gov/pubmed/32450807
http://dx.doi.org/10.1186/s12865-020-00360-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249306/
https://www.ncbi.nlm.nih.gov/pubmed/32450807
http://dx.doi.org/10.1186/s12865-020-00360-1

Ejemplares similares